Author:
Ishibane Misaki,Hashimoto Hirofumi,Kaneko Meika,Saito Shota,Pae Sangjon,Saito Shinpei,Reien Yoshie,Hirayama Yuri,Higashi-Kuwata Nobuyo,Mitsuya Hiroaki,Anzai Naohiko
Funder
National Institutes of Health
National Cancer Institute
Japan Agency for Medical Research and Development
Subject
Pharmacology,Molecular Medicine
Reference10 articles.
1. Drafting committee for hepatitis management guidelines, the Japan society of hepatology. Japan society of hepatology guidelines for the management of hepatitis B virus infection: 2019 update;Hepatology Pesearch,2020
2. Identification of a novel long-acting 4'-modified nucleoside reverse transcriptase inhibitor against HBV;Higashi-Kuwata;J Hepatol,2021
3. Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: a case report;Novick;Medicine (Baltimore),2017
4. Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity;Takeda;Kidney Int,1999